Folate receptor-targeted antioxidant therapy ameliorates renal ischemia-reperfusion injury

Journal of the American Society of Nephrology

Volumn 23, Issue 5, 2012, Pages 793-800

  Knight, Sarah F ^a   Kundu, Kousik ^b,c   Joseph, Giji ^a   Dikalov, Sergey ^a   Weiss, Daiana ^a   Murthy, Niren ^b,c   Taylor, W Robert ^a,b,c,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Emory University   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^d ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTEMPOL FOLATE; CREATININE; FOLATE RECEPTOR 1; FOLIC ACID DERIVATIVE; HYDROETHIDINE; NITROGEN; SUPEROXIDE; TEMPOL; UNCLASSIFIED DRUG; UREA;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG CONJUGATION; DRUG EFFECT; ELECTRON SPIN RESONANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; INTESTINE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SKELETAL MUSCLE; TUBULAR DYSFUNCTION; UREA NITROGEN BLOOD LEVEL;

EID: 84859007617     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011070711     Document Type: Article

References (48)

1. Devarajan P, Mishra J, Supavekin S, Patterson LT, Steven Potter S: Gene expression in early ischemic renal injury: Clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Genet Metab 80: 365-376, 2003 (Pubitemid 37491197)
2. Shoskes DA: Nonimmunologic renal allograft injury and delayed graft function: Clinical strategies for prevention and treatment. Transplant Proc 32: 766-768, 2000
3. Perico N, Cattaneo D, Sayegh MH, Remuzzi G: Delayed graft function in kidney transplantation. Lancet 364: 1814-1827, 2004 (Pubitemid 39488068)
4. Paller MS, Hoidal JR, Ferris TF: Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 74: 1156-1164, 1984 (Pubitemid 15206810)
5. Li C, Jackson RM: Reactive species mechanisms of cellular hypoxiareoxygenation injury. Am J Physiol Cell Physiol 282: C227-C241, 2002 (Pubitemid 34663181)
6. Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, Fujita T, Brodsky S, Goligorsky MS: Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 281: F948-F957, 2001
7. Daemen MA, van 't Veer C, Denecker G, Heemskerk VH, Wolfs TG, Clauss M, Vandenabeele P, Buurman WA: Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 104: 541-549, 1999
8. Williams P, Lopez H, Britt D, Chan C, Ezrin A, Hottendorf R: Characterization of renal ischemia-reperfusion injury in rats. J Pharmacol Toxicol Methods 37: 1-7, 1997 (Pubitemid 27150639)
9. Goligorsky MS: Whispers and shouts in the pathogenesis of acute renal ischaemia. Nephrol Dial Transplant 20: 261-266, 2005
10. Yamanobe T, Okada F, Iuchi Y, Onuma K, Tomita Y, Fujii J: Deterioration of ischemia/reperfusion-induced acute renal failure in SOD1-deficient mice. Free Radic Res 41: 200-207, 2007 (Pubitemid 46992870)
11. Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P: Differential gene expression following early renal ischemia/reperfusion. Kidney Int 63: 1714-1724, 2003 (Pubitemid 36513317)
12. Snoeijs MG, Vink H, Voesten N, Christiaans MH, Daemen JW, Peppelenbosch AG, Tordoir JH, Peutz-Kootstra CJ, Buurman WA, Schurink GW, van Heurn LW: Acute ischemic injury to the renal microvasculature in human kidney transplantation. Am J Physiol Renal Physiol 299: F1134-F1140, 2010
13. Chatterjee PK, Cuzzocrea S, Brown PA, Zacharowski K, Stewart KN, Mota-Filipe H, Thiemermann C: Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 58: 658-673, 2000 (Pubitemid 30620015)
14. Ye J, Li J, Yu Y, Wei Q, Deng W, Yu L: L-carnitine attenuates oxidant injury in HK-2 cells via ROS-mitochondria pathway. Regul Pept 161: 58-66, 2010
15. Metz JM, Smith D, Mick R, Lustig R, Mitchell J, Cherakuri M, Glatstein E, Hahn SM: A phase I study of topical Tempol for the prevention of alopecia induced bywhole brain radiotherapy. Clin Cancer Res 10: 6411-6417, 2004 (Pubitemid 39346535)
16. Waters DD, Alderman EL, Hsia J, Howard BV, Cobb FR, Rogers WJ, Ouyang P, Thompson P, Tardif JC, Higginson L, Bittner V, Steffes M, Gordon DJ, Proschan M, Younes N, Verter JI: Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized controlled trial. JAMA 288: 2432-2440, 2002 (Pubitemid 35340539)
17. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E: Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142: 37-46, 2005
18. Ristow M, Zarse K, Oberbach A, Klöting N, Birringer M, Kiehntopf M, Stumvoll M, Kahn CR, Blüher M: Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci USA 106: 8665-8670, 2009
19. Chatterjee PK: Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: A comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 376: 1-43, 2007
20. Fujii T, Takaoka M, Ohkita M, Matsumura Y: Tempol protects against ischemic acute renal failure by inhibiting renal noradrenaline overflow and endothelin-1 overproduction. Biol Pharm Bull 28: 641-645, 2005 (Pubitemid 40879930)
21. Deelman LE, Declèves AE, Rychak JJ, Sharma K: Targeted renal therapies through microbubbles and ultrasound. Adv Drug Deliv Rev 62: 1369-1377, 2010
22. Stokman G, Qin Y, Rácz Z, Hamar P, Price LS: Application of siRNA in targeting protein expression in kidney disease. Adv Drug Deliv Rev 62: 1378-1389, 2010
23. Molitoris BA, Dagher PC, Sandoval RM, Campos SB, Ashush H, Fridman E, Brafman A, Faerman A, Atkinson SJ, Thompson JD, Kalinski H, Skaliter R, Erlich S, Feinstein E: siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J Am Soc Nephrol 20: 1754-1764, 2009
24. Szeto HH, Liu S, Soong Y, Wu D, Darrah SF, Cheng FY, Zhao Z, Ganger M, Tow CY, Seshan SV: Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol 22: 1041-1052, 2011
25. Birn H, Spiegelstein O, Christensen EI, Finnell RH: Renal tubular reabsorption of folate mediated by folate binding protein 1. J Am Soc Nephrol 16: 608-615, 2005 (Pubitemid 41725097)
26. da Costa M, Rothenberg SP, Sadasivan E, Regec A, Qian L: Folate deficiency reduces the GPI-anchored folate-binding protein in rat renal tubules. Am J Physiol Cell Physiol 278: C812-C821, 2000 (Pubitemid 30211312)
27. Birn H, Nielsen S, Christensen EI: Internalization and apical-to-basolateral transport of folate in rat kidney proximal tubule. Am J Physiol 272: F70-F78, 1997 (Pubitemid 27382281)
28. Sandoval RM, Kennedy MD, Low PS, Molitoris BA: Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy. Am J Physiol Cell Physiol 287: C517-C526, 2004 (Pubitemid 38955243)
29. McMartin KE, Morshed KM, Hazen-Martin DJ, Sens DA: Folate transport and binding by cultured human proximal tubule cells. Am J Physiol 263: F841-F848, 1992
30. Hurrell RF: Influence of vegetable protein sources on trace element and mineral bioavailability. J Nutr 133: 2973S-2977S, 2003
31. Dotan Y, Lichtenberg D, Pinchuk I: No evidence supports vitamin E indiscriminate supplementation. Biofactors 35: 469-473, 2009
32. Elnakat H, Gonit M, Salazar MD, Zhang J, Basrur V, Gunning W, Kamen B, Ratnam M: Regulation of folate receptor internalization by protein kinase C alpha. Biochemistry 48: 8249-8260, 2009
33. Zhao X, Li H, Lee RJ: Targeted drug delivery via folate receptors. Expert Opin Drug Deliv 5: 309-319, 2008 (Pubitemid 351454380)
34. Ashokkumar B, Mohammed ZM, Vaziri ND, Said HM: Effect of folate oversupplementation on folate uptake by human intestinal and renal epithelial cells. Am J Clin Nutr 86: 159-166, 2007 (Pubitemid 47041606)
35. Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt HH, Harrison DG, Griendling KK: Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med 45: 1340-1351, 2008
36. Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, Leamon CP: Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem338: 284-293, 2005 (Pubitemid 40312593)
37. Luo Z, Chen Y, Chen S, Welch WJ, Andresen BT, Jose PA, Wilcox CS: Comparison of inhibitors of superoxide generation in vascular smooth muscle cells. Br J Pharmacol 157: 935-943, 2009
38. Antony AC: Folate receptors. Annu Rev Nutr 16: 501-521, 1996
39. Dikalov S, Griendling KK, Harrison DG: Measurement of reactive oxygen species in cardiovascular studies. Hypertension 49: 717-727, 2007 (Pubitemid 351688335)
40. Paller MS: The cell biology of reperfusion injury in the kidney. J Investig Med 42: 632-639, 1994
41. Thadhani R, Pascual M, Bonventre JV: Acute renal failure. N Engl J Med 334: 1448-1460, 1996 (Pubitemid 126590563)
42. Snoeijs MG, van Heurn LW, Buurman WA: Biological modulation of renal ischemia-reperfusion injury. Curr Opin Organ Transplant 15: 190-199, 2010
43. Wilcox CS: Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol Ther 126: 119-145, 2010
44. Steinhubl SR: Why have antioxidants failed in clinical trials? Am J Cardiol 101[10A]: 14D-19D, 2008
45. Crich D, Grant D, Bowers AA: Heterobivalent library expansion by "living radical" processes: Thiocarbonyl addition/elimination, and nitroxide-based reactions with fluorous deconvolution. J Am Chem Soc 129: 12106-12107, 2007 (Pubitemid 47556842)
46. Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, Ruhrberg C, Cantley LG: Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 22: 317-326, 2011
47. Jang HS, Kim J, Park YK, Park KM: Infiltrated macrophages contribute to recovery after ischemic injury but not to ischemic preconditioning in kidneys. Transplantation 85: 447-455, 2008 (Pubitemid 351322770)
48. Kim J, Jung KJ, Park KM: Reactive oxygen species differently regulate renal tubular epithelial and interstitial cell proliferation after ischemia and reperfusion injury. Am J Physiol Renal Physiol 298: F1118-F1129, 2010